Give Once
Make a one-time donation
Give Monthly
Become a monthly supporter
Give in Memory
Make a dedicated donation, find or create a tribute page
Start a Fundraiser
Find a fundraising page or create your own
search modal
Home test modal
Cancer
New Therapies for Brain Cancer
Glioblastoma: New Therapies for Brain Cancer
Launched
2019 June
<p><strong></strong>Glioblastoma is a deadly disease, but researchers at the MUHC have uncovered a therapy that may change the prognosis for patients.<em></em></p>
Glioblastoma is a deadly disease, but researchers at the MUHC have uncovered a therapy that may change the prognosis for patients.
It’s a diagnosis that can devastate a patient – glioblastoma multiforme. It is an extremely aggressive brain tumor that is resistant to treatment. Radiotherapy, chemotherapy, even extensive attempts to remove the tumor surgically cannot force the cancer into remission, leaving physicians with few options. Despite the emergence of intensive treatment strategies, the median survival of patients with glioblastoma is 16 months and only 3-5% of patients survive longer than 3 years.
Progress
Money raised to date
$ 0
01
What
Glioblastoma and the MUHC
In response to the devastation of glioblastoma, Dr. Bassam Abdulkarim of the Research Institute of the McGill University Health Centre (RI-MUHC) is working with a diverse team of physicians and researchers to discover new therapies for patients diagnosed with glioblastoma. After years of research and development, the MUHC’s Cancer Therapeutics Research Team is proud to have discovered a promising new therapy, called ZR2002. The drug will soon be ready for clinical trials, the first step toward making it available to patients.
